Patents by Inventor Himanshu Patel

Himanshu Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11941392
    Abstract: An ambulatory medical device can detect a device condition and determine if the device condition satisfies a set of normal operating parameters. If the normal operating parameters are not satisfied, the ambulatory medical device can determine if the device condition stratifies a set of minimum operating parameters. If the minimum operating parameters are satisfied, the ambulatory medical device can maintain a delivery of therapy to a subject and generate an alert based on the device condition.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: March 26, 2024
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib, David Chi-Wai Lim
  • Patent number: 11925788
    Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: March 12, 2024
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Firas H. El-Khatib, Himanshu Patel
  • Publication number: 20240062867
    Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 22, 2024
    Applicant: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Firas El-Khatib, Himanshu Patel, Michael Rosinko, David Henderson, Justin Brown
  • Publication number: 20240056830
    Abstract: The present disclosure provides a system and method for facilitating tracking area code (TAC) engine to prepare dynamic network polygons based on actual configuration, allocation of TAC to new cell sites, identification of various discrepancies and anomalies in existing planned network, capacity optimization through TAC Division, merge and network polygon edit, and auto work order generation and execution of changes in respective systems, MME Pool and eNB/SCs. Tracking Area Code is a vital parameter for new sites planning and rollout. The method complements network rollout speed with highest level of accuracy of planning and better network perform nave and accuracy. Auto planning engine makes TAC planning zero touch engine with manual review and action through manual edit, audit and work order creation features. Auto planning and configuration help faster rollout, speedy correction and implementation in live network to enhance network performance and user experience.
    Type: Application
    Filed: May 31, 2022
    Publication date: February 15, 2024
    Inventors: Aayush BHATNAGAR, Haresh AMBALIYA, Vikram SINGH, Himanshu PATEL, Manish PATEL, Arunima SARKAR
  • Publication number: 20240024578
    Abstract: A glucose level control system may be configured to determine that certain status information fails to satisfy at least one of a plurality of safety thresholds. The system may receive status information, which may include device information pertaining to a condition of the ambulatory medicament device and/or subject information pertaining to a condition of a subject. The system can determine that the status information fails to satisfy the safety threshold(s). In response to determining that the status information fails to satisfy the at least one of a plurality of safety thresholds, the system can automatically execute a distress action. Example safety thresholds include a glucose level of a subject being less than a minimum threshold, a glucose level of a subject being greater than a maximum threshold, a movement of the subject being less than a minimum movement threshold for a threshold amount of time, and/or other safety thresholds.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 25, 2024
    Inventors: Himanshu Patel, Michael J. Rosinko, Firasd H. El-Khatib, Edward R. Damiano
  • Publication number: 20230405224
    Abstract: A glucose level control system may be configured to determine a recommended medicament dose based at least in part on a subject's therapy data and/or user-specified medicament related inputs. The therapy data may include glucose level data and medicament delivery data. The user-specified medicament related inputs may include qualitative meal announcements. For example, the user can specify that the subject consumed a small, medium, or large meal. The glucose level control system may be configured to output an indication of the recommended medicament dose to a display. The glucose level control system may be configured to output a dose control signal to preconfigure a smart pen to deliver the recommended medicament dose. The glucose level control system may be configured to generate an alert if it determines, based at least in part on glucose level data and/or medicament delivery data associated with the subject, that trigger criteria have been satisfied.
    Type: Application
    Filed: April 6, 2023
    Publication date: December 21, 2023
    Inventors: Michael J. Rosinko, Himanshu Patel, Firas H. El-Khatib
  • Patent number: 11803367
    Abstract: Systems and methods are disclosed herein for monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device. The ambulatory medical device can have a touchscreen display user interface to receive input signals from a user and display alarm conditions associated with the status of an ambulatory medical device or health condition of a subject. The disclosed methods and systems can determine whether status information received from a monitoring system interface satisfies an alarm condition for the ambulatory medicament device or for the subject. If the status information satisfies an alarm condition, the touchscreen user interface can display one or more alarm status indicators corresponding to the alarm condition. The user can activate a therapy change interface on the touchscreen display and modify a control parameter of the ambulatory medical device that controls the therapy delivery to the subject.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: October 31, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, Justin P. Brown, Bryan Dale Knodel, Himanshu Patel
  • Publication number: 20230337949
    Abstract: A glucose level control system may be configured to determine that certain status information fails to satisfy at least one of a plurality of safety thresholds. The system may receive status information, which may include device information pertaining to a condition of the ambulatory medicament device and/or subject information pertaining to a condition of a subject. The system can determine that the status information fails to satisfy the safety threshold(s). In response to determining that the status information fails to satisfy the at least one of a plurality of safety thresholds, the system can automatically execute a distress action. Example safety thresholds include a glucose level of a subject being less than a minimum threshold, a glucose level of a subject being greater than a maximum threshold, a movement of the subject being less than a minimum movement threshold for a threshold amount of time, and/or other safety thresholds.
    Type: Application
    Filed: April 19, 2023
    Publication date: October 26, 2023
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20230338643
    Abstract: A glucose level control system can intermittently receive alarm data corresponding to instances where an alarm was triggered and receive a request for the remote support system to contact the user. The system can transmit the request to the remote support system and determine that at least one of a plurality of support system criteria are satisfied. The control system can automatically identify a category of concern related to the request and generate a report of usage based on the category of concern and on the alarm data. The control system may transmit the report of usage to a remote electronic device and determine a support resource configured to receive the report of usage associated with the glucose level control system. The control system can generate a connection alert that is configured to request contact with a support request interface operatively coupled to the ambulatory medicament pump.
    Type: Application
    Filed: April 18, 2023
    Publication date: October 26, 2023
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: 11776374
    Abstract: The present invention provides an improved electronic fall monitoring system comprising a device having multiple sensor ports for flexibly monitoring various sensors associated with a single patient without requiring repeated connections and disconnections of sensors. With several sensors simultaneously connected at different locations, a processor can execute to ensure that only one sensor, corresponding to one patient, is monitored at any given time, including by triggering an alarm when a second sensor is triggered while a first sensor is in use. Accordingly, the system can provide a “one step transfer” in which a caregiver may simply press hold once to transfer a patient from one sensed area to another. In addition, the caregiver can simply actuate a single input with only a momentary press to allow suspension of monitoring for a shorter duration (hold) or a longer press to allow suspension of monitoring for a longer duration (extended hold).
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: October 3, 2023
    Assignee: TIDI Products, LLC
    Inventors: Roy Seizo Carr, Glen Holt Humphrey, Drew Deem Coatney, Himanshu Patel, Lisa McHale, Brian N. Young, Justin K. Thomas
  • Patent number: 11768676
    Abstract: Systems and methods are disclosed herein for switching control of an ambulatory medical device from an application executing on the ambulatory medical device to a safe version or a new version of the application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device can maintain copies of a safe version and a new version of the application. The disclosed systems and methods can execute the new version, while the prior version of the application continues to execute, determine whether a minimum set of operating conditions are satisfied by the new version, and switch control of the ambulatory medical device from the prior version to the new version. The systems and methods can also automatically revert to the safe version of the application case the current version is malfunctioning without interrupting therapy provided to the subject.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: September 26, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, Himanshu Patel, John R. Costik, Justin P. Brown, Bryan Dale Knodel
  • Publication number: 20230298724
    Abstract: A medical device, such as an ambulatory medicament pump or associate control system, can receive a use state comprising user interactions with the glucose level control system. The device can determine that the use state satisfies at least one of a plurality of user interaction criteria. The plurality of user interaction criteria can include a variety of various interaction criteria. In response to determining that the use state satisfies the at least one of the plurality of user interaction criteria, the system can automatically generate the user alert comprising a link to training content. The link can direct a user to the training content in response to user interaction with the link.
    Type: Application
    Filed: March 17, 2023
    Publication date: September 21, 2023
    Applicant: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: 11698785
    Abstract: Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: July 11, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Himanshu Patel, Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, John R. Costik, Justin P. Brown, Bryan Dale Knodel
  • Publication number: 20230201659
    Abstract: A system and method for optimizing a patient's Kegel exercises is provided. The system includes a user interface device and a vaginal device. The vaginal device includes an intra-vaginal probe having an accelerometer that is configured to generate a signal in response to movement of the probe. The user interface device is connected to the vaginal device and analyzes signals from the accelerometer to provide physiological feedback information to the patient. The vaginal device may be connected to the user interface device via wireless communications such as Bluetooth or by wire. The user interface device may be a smart device or a computer that transmits information to central web-based data server accessible by the patient or authorized healthcare providers or third-party payers.
    Type: Application
    Filed: August 29, 2022
    Publication date: June 29, 2023
    Inventors: Ramon Jose IGLESIAS, David J. MISHELEVICH, Sean C. NASH, Kaitlin B. SCHAEFER, Jahnavi LOKRE, Milan V. TRCKA, Himanshu PATEL, Jan B. ZWIERSTRA, Trevor DUNLOP, Aaron GIFFORD
  • Patent number: 11688501
    Abstract: Systems and methods are disclosed herein for managing access to therapy controls of an ambulatory medicament pump that provides therapy to a subject using safe access levels associated with the therapy controls. The therapy change controls may enable modification of the corresponding therapy control parameters. The disclosed systems and methods can determine the eligibility of a subject receiving therapy from the ambulatory medicament pump or a user of the ambulatory medicament pump, for a safe access level and provide access to the corresponding therapy change controls. The ambulatory medicament pump may provide access to the therapy change controls upon receiving an access signal. In some cases, the ambulatory medicament pump may receive a time-based passcode and provide access to the therapy change controls upon receiving a matching passcode from the user.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: June 27, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Edward R. Damiano, Himanshu Patel, Firas H. El-Khatib, Robert James LeBourdais
  • Patent number: 11610661
    Abstract: Systems and methods are disclosed herein for managing access to therapy controls of an ambulatory medicament pump that provides therapy to a subject using safe access levels associated with the therapy controls. The therapy change controls may enable modification of the corresponding therapy control parameters. The disclosed systems and methods can determine the eligibility of a subject receiving therapy from the ambulatory medicament pump or a user of the ambulatory medicament pump, for a safe access level and provide access to the corresponding therapy change controls. The ambulatory medicament pump may provide access to the therapy change controls upon receiving an access signal. In some cases, the ambulatory medicament pump may receive a time-based passcode and provide access to the therapy change controls upon receiving a matching passcode from the user.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: March 21, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Edward R. Damiano, Himanshu Patel, Firas H. El-Khatib, Robert James LeBourdais
  • Patent number: 11610662
    Abstract: Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: March 21, 2023
    Assignee: Beta Bionics, Inc
    Inventors: Edward R. Damiano, Firas H. El-Khatib, Himanshu Patel, Michael J. Rosinko, Robert James LeBourdais
  • Patent number: 11594314
    Abstract: Blood glucose control systems are disclosed. A blood glucose control system can receive a glucose level signal from a glucose sensor operatively coupled to a subject. The system can decode encoded data of the glucose level signal to obtain the glucose level of the subject and the indication of the glucose trend. The system can automatically calculate the dose control signal using a control algorithm configured to calculate regular correction boluses of glucose control agent in response to at least the glucose level of the subject. The system can select a dose control signal encoding profile from a plurality of dose control signal encoding profiles and, based on the dose control signal encoding profile, encode the dose control signal such that the pump controller can read the dose control signal. The system can transmit an encoded dose control signal to the pump controller.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: February 28, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: 11587664
    Abstract: Systems and methods are disclosed herein for providing a configuration code for customizing a glucose level control system for at least an initial period. The configuration code can be based on one or more dosing parameters from a tracked medicament therapy administered to a subject over a tracking period by the glucose level control system. The configuration code includes encoded dosing parameters including a correction dosing parameter based on at least some of the correction boluses of medicament administered during the tracking period, a food intake dosing parameter comprising an indication of a food intake bolus size of medicament based on one or more food intake boluses provided during the tracking period, and a basal dosing parameter based on at least some of the basal doses of medicament administered during the tracking period.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: February 21, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Firas H. El-Khatib, Himanshu Patel, Edward R. Damiano, Michael J. Rosinko
  • Patent number: 11565041
    Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: January 31, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Himanshu Patel, Justin P. Brown